BACKGROUND: Concerns remain about the safety of adding long-acting β2-agonists to inhaled glucocorticoids for the treatment of asthma. In a postmarketing safety study mandated by the Food and Drug Administration, we evaluated whether the addition of formoterol to budesonide maintenance therapy incre...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!